Navigation Links
Campbell Alliance Adds Doug Linton, Former Cardinal Health Executive, to Executive Advisory Group
Date:4/28/2008

RALEIGH, N.C., April 28 /PRNewswire/ -- Campbell Alliance, the leading management consulting firm specializing in the pharmaceutical and biotech industry, today announced that Doug Linton has joined its Executive Advisory Group. The group is made up of industry professionals brought together by Campbell Alliance CEO John Campbell to bring special expertise to highly complex engagements. Mr. Linton will focus on distribution-related issues, working closely with Campbell Alliance's Trade and Distribution Practice.

Mr. Linton started with Cardinal Health, a global manufacturer and distributor of medical and surgical supplies and technologies, in 1981, and he has worked in the pharmaceutical distribution field for more than 20 years. At Cardinal, he played a key role developing the sophisticated investment buying program and central purchasing system that powered the firm's consolidation strategy, which transformed it from a small regional player in the early 1980s to a highly profitable national drug wholesaler by the mid- 1990s. Mr. Linton also developed and was president of several very profitable new business units for Cardinal, including National PharmPak Services, a re- packaging company, and National Specialty Services, which focused on distribution of plasma and oncology products. Mr. Linton reported to the founder and CEO of Cardinal Health during a majority of his tenure and was a member of senior management.

After leaving Cardinal in 1995, Mr. Linton worked as a senior executive with two regional drug wholesalers to develop purchasing capabilities similar to those he established at Cardinal. He then returned to Cardinal as a consultant to develop an analytical fee-for-service program for smaller manufacturers, and he directed its implementation with more than 60 manufacturers in less than twelve months. Today that program is used with close to 200 manufacturers.

After leaving Cardinal two years ago, Mr. Linton consulted to over 20 pharmaceutical companies. In addition, he served as a member of the board of directors of Bradley Pharmaceuticals from November 2006 until February 2008, when it was acquired by Nycomed.

"Doug adds a wealth of expertise to the team working on complex trade and distribution-related issues here at the firm. Doug's leadership and the practical experience he has amassed over the past two decades will undoubtedly help guide our efforts to serve the pharmaceutical and biotech companies that depend on us for this expertise," stated Tony Lanzone, vice president and head of the Trade and Distribution Practice at Campbell Alliance.

Mr. Linton graduated with a degree in Economics with honors from the College of Wooster (Ohio) and an MBA from Carnegie Mellon University.

About the Trade and Distribution Practice at Campbell Alliance

The Trade and Distribution Practice at Campbell Alliance focuses on helping clients make better strategic decisions surrounding distribution- related business challenges at the product, portfolio, and corporate levels. Services include:
-- Comprehensive trade assessments, including primary and secondary

research

-- Trade strategy development, including opportunity and issue

identification, prioritization, and implementation support

-- Trade launch strategy, including channel and message strategies,

stocking plans, and trade program analysis and planning

-- Specialty pharmacy strategy, including market analysis and contracting

planning

-- Trade program analytics to measure return-on-investment and direct

promotional resource allocation

About Campbell Alliance

Campbell Alliance is the leading management consulting firm specializing in the pharmaceutical and biotechnology industry. The firm's clients include most of the world's top-20 pharmaceutical companies, as well as numerous emerging and midsize firms. Campbell Alliance is organized into practice areas, each specializing in a critical industry function, including Brand Management, Business Development, Clinical Development, Managed Markets, Sales, and Trade and Distribution. From its locations in Raleigh, NC, Parsippany, NJ, Los Angeles, San Francisco, Chicago, Boston, Philadelphia, New York City, and Atlanta, the firm serves clients throughout North America, Europe, and Japan. For more information on Campbell Alliance, please visit http://www.campbellalliance.com.

CONTACT:

James Forte

Director, Public and Media Relations

Campbell Alliance

919-844-7100, extension 7195

jforte@campbellalliance.com


'/>"/>
SOURCE Campbell Alliance
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Campbell Alliance to Moderate Senior-Level Panel Discussion at Windhover Pharmaceutical Strategic Alliances Conference
2. Campbell Alliance Managed Markets Practice to Take Leadership Role at CBIs Formulary and Reimbursement Conference
3. Campbell Alliance Named Best Place to Work by Triangle Business Journal
4. Campbell Alliance Business Development Practice to Moderate Two Workshops at LES Annual Meeting in Vancouver
5. Campbell Alliance Launches New Practice Area Focused on Trade and Distribution
6. Campbell Alliance Trade and Distribution Practice to Chair CBI 3rd Annual Fee for Service and EDI Data Management Conference
7. Campbell Alliance Brand Management Practice to Discuss Managing Launch Logistics at the EyeForPharma Oncology Summit
8. Campbell Alliance Brand Management and Managed Markets Practices to Speak at CBIs Early Commercialization Conference
9. Campbell Alliance Sales Practice to Conduct Workshop at EyeForPharma SFE Europe Conference
10. Campbell Alliance Managed Markets Practice to Take a Leadership Role at the CBI Forum on Effective Product Pricing and Modeling Strategies
11. Heritage and Ipca Enter Into Strategic Alliance for Generic Pharmaceutical Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... TORONTO , June 23, 2016 /PRNewswire/ - ... Ontario biotechnology company, Propellon ... the development and commercialization of a portfolio of ... cancers. Epigenetic targets such as WDR5 represent an ... contribute significantly in precision medicine for cancer patients. ...
(Date:6/23/2016)... , June 23, 2016 Houston ... with the Cy-Fair Sports Association to serve as ... the agreement, Houston Methodist Willowbrook will provide sponsorship ... and connectivity with association coaches, volunteers, athletes and ... with the Cy-Fair Sports Association and to bring ...
(Date:6/23/2016)... Prostate Cancer Foundation (PCF) is pleased to announce 24 new Young ... cancer. Members of the Class of 2016 were selected from a pool of ... More About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... , June 23, 2016   EpiBiome , ... secured $1 million in debt financing from Silicon Valley ... up automation and to advance its drug development efforts, ... new facility. "SVB has been an incredible ... the services a traditional bank would provide," said Dr. ...
Breaking Biology Technology:
(Date:5/3/2016)... VILNIUS, Lithuania , May 3, 2016 /PRNewswire/ ... today released the MegaMatcher Automated Biometric Identification ... deployment of large-scale multi-biometric projects. MegaMatcher ABIS can ... and accuracy using any combination of fingerprint, face ... of MegaMatcher SDK and MegaMatcher ...
(Date:4/26/2016)... and LONDON , April 26, ... of EdgeVerve Systems, a product subsidiary of Infosys ... announced a partnership to integrate the Onegini mobile ...      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ) ... customers enhanced security to access and transact across ...
(Date:4/15/2016)... , April 15, 2016  A new ... make more accurate underwriting decisions in a fraction ... timely, competitively priced and high-value life insurance policies ... screenings. With Force Diagnostics, rapid testing ... lifestyle data readings (blood pressure, weight, pulse, BMI, ...
Breaking Biology News(10 mins):